维普中文期刊产品整合服务
9篇 您的检索式:作者名="DHARMINDER C"
    题名 作者 年代 出处 被引量
1Combina- tion of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma 显示文摘DHARMINDER C AJITA VS BRYAN C 2010Blood2010,115,4:1
2Targeting mitochondrial factor smac/DIABLO as therapy for multiple myeloma 显示文摘Dharminder C Paola N Mugdha V 2007Blood2007,109,3:1
3Thalidomide and its analogus overcome drug resistance of human multiple myeloma cells to conventional therapy显示文摘Teru H Dharminder C Yoshihito S 2000Blood2000,96,9:1
4IL-6 triggers cell growth via the ras-dependent mitogen-activated protein kinase cascade 显示文摘ATSUSHI O DHARMINDER C GERRARD T 1997J Immunol1997,159,:1
5Proteasome in- hibitor therapy in multiple myeloma显示文摘Dharminder C Tenl H Constantine M 2005Mol Cancer Ther2005,4,4:1
6NK dependent release of mitochondrial Protein, Smac, during Apoptosis in Multiple Myeloma (MM) Cells 显示文摘Dharminder C Guilan L Teru H 2003J Biol Chem2003,278,17:1
7Thalidomide and its analogus overcome drug resistance of human multiple myeloma cells to conventional therapy显示文摘Teru H Dharminder C 2000Blood2000,96,9:1
8IL-6 treggers cell growth via the ras-dependent mitogen-activated protein kinase cascade显示文摘ATSUSHI O DHARMINDER C GERRARD T 1997J Immunol1997,159,:1
9Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma 显示文摘Dharminder C Paola N Mugdha V 2007Blood2007,109,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费